Patents Assigned to The University Hospital
  • Patent number: 11795224
    Abstract: The present disclosure provides an anti-T-cell nanobody that specifically binds to CD3 ?. The present disclosure also provides the nucleic acid sequence of the anti-T-cell nanobody, use of the anti-T-cell nanobody for treating cancer, immunoregulation and activating immune cells, and a method for detecting expression levels of CD3 ?.
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: October 24, 2023
    Assignee: CHINA MEDICAL UNIVERSITY HOSPITAL
    Inventors: Der-Yang Cho, Shao-Chih Chiu, Shi-Wei Huang, Chih-Ming Pan, Mei-Chih Chen, Yu-Chuan Lin, Yeh Chen
  • Publication number: 20230330179
    Abstract: A composition suitable for preventing or treating an inflammatory disease is disclosed. The composition contains zinc finger protein with KRAB and SCAN domains 8 (Zkscan8) protein, which has a superior effect of effectively inhibiting inflammatory responses by inhibiting the expression of inflammatory cytokines and promoting the expression of anti-inflammatory factors. Therefore, the composition can be effectively used for preventing or treating an inflammatory disease.
    Type: Application
    Filed: July 2, 2021
    Publication date: October 19, 2023
    Applicant: SEOUL NATTIONAL UNIVERSITY HOSPITAL
    Inventors: Hyun Chul JO, Ah-Young LEE, JI-Hye YEA
  • Patent number: 11785922
    Abstract: Provided are a protein complex in which estrogen receptor 2 (-ERT2) is fused to CRISPR associated protein 9 (Cas9), and a recombinant vector carrying a gene coding the protein complex, wherein ERT2 is bonded to the N-terminus and C-terminus of nuclear localization sequence (NLS)-removed Cas9 and the complex has the advantage of translocating from the cytosol into the nucleus at a certain time point upon treatment with tamoxifen and modifying a specific DNA with the aid of guide RNA (gRNA), ultimately enabling a more elaborate DNA modification operation in a desired part at a desired time point.
    Type: Grant
    Filed: May 3, 2018
    Date of Patent: October 17, 2023
    Assignee: SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Eun Ju Lee, Hyo-Soo Kim
  • Patent number: 11779222
    Abstract: The disclosure provides a method of and an imaging system for clinical sign detection. The method uses an imaging system having an RGB image sensor and the processing device disclosed herein. An image of a patient or examinee is captured by the RGB image sensor to generate an RGB image. Clinical signs of the patient or examinee are detected by the processing device based on the RGB images.
    Type: Grant
    Filed: July 9, 2020
    Date of Patent: October 10, 2023
    Assignees: COMPAL ELECTRONICS, INC., National Taiwan University Hospital
    Inventors: Tung-Hung Su, Cheng-Fu Chou, Shann-Ching Chen
  • Patent number: 11771318
    Abstract: The present invention relates to a method for supporting reading of a fundus image of a subject, and a computing device using the same. Specifically, the computing device according to the present invention acquires the fundus image of the subject, extracts attribute information from the fundus image on the basis of a machine learning model for extracting the attribute information of the fundus image, and provides the extracted attribute information to an external entity. In addition, when evaluation information on the extracted attribute information or modification information on the attribute information is acquired, the computing device according to the present invention can also update the machine learning model on the basis of the acquired evaluation information or modification information.
    Type: Grant
    Filed: July 18, 2018
    Date of Patent: October 3, 2023
    Assignees: VUNO, INC., SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Sang Jun Park, Joo Young Shin, Jae Min Son, Sang Keun Kim, Kyuhwan Jung, Hyun-Jun Kim
  • Patent number: 11774388
    Abstract: As one example, an apparatus includes a dielectric microsensor having a microfluidic chamber that includes a capacitive sensing structure. The microfluidic chamber is adapted to receive a volume of a blood sample, and a bioactive agent is adapted to interact with the blood sample, as a sample under test (SUT), within the microfluidic chamber. A transmitter can provide an input radio frequency (RF) signal to the dielectric microsensor, and a receiver can receive an output RF signal from the dielectric microsensor. A computing device is configured to compute dielectric permittivity values for the SUT based on the output RF signal over a time interval in which the dielectric permittivity values are representative of the bioactive agent interacting with the blood sample over the time interval. The computing device is further configured to provide a readout representative of hemostatic dysfunction for the blood sample based on the dielectric permittivity values.
    Type: Grant
    Filed: June 29, 2022
    Date of Patent: October 3, 2023
    Assignees: CASE WESTERN RESERVE UNIVERSITY, UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
    Inventors: Pedram Mohseni, Lalitha Nayak, Michael Suster, Sina Pourang
  • Publication number: 20230296583
    Abstract: Provided are an apparatus for diagnosing a disease and a method for diagnosing same. The apparatus includes a pump for pumping respiratory gas, a first pre-treatment portion connected to the pump and removing moisture and bad breath in the respiratory gas, and a volatile organic compound detector connected between the first pre-treatment portion and the pump and detecting volatile organic compounds in the respiratory gas.
    Type: Application
    Filed: October 31, 2022
    Publication date: September 21, 2023
    Applicants: ELECTRONICS AND TELECOMMUNICATIONS RESEARCH INSTITUTE, SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Dae-Sik LEE, Sang Hoon JHEON, Hyung-Kun LEE, Yoohwa HWANG, Doyeob KIM, Chang-Beom KIM, Jin Oh LEE
  • Patent number: 11759330
    Abstract: The present invention provides a supporting member and a supporting member assembly including the same to be implanted into or between a subject's bones, and a template plug and a tamper corresponding to the supporting member. The supporting member comprises a main body; a first connecting portion and a second connecting portion formed on the upper and lower sides of the main body respectively and forming a dovetail joint with each other; and a guiding structure formed at a side of the main body and including guiding holes as well as a buffer groove for mating with an external template plug. The supporting members of the invention can be sequentially implanted and connected into a bone or between two connected bones, and improve the defect of the conventional one-size giant implants injuring the surrounding nerves.
    Type: Grant
    Filed: November 16, 2020
    Date of Patent: September 19, 2023
    Assignee: NATIONAL TAIWAN UNIVERSITY HOSPITAL JINSHAN BRANCH
    Inventor: Jui-Yang Hsieh
  • Publication number: 20230288582
    Abstract: The disclosure relates to a device for detecting therapeutic radiation based on an optical disk with solar cells. The radiation detecting device may include at least one optical disk formed of a water-equivalent material, disposed perpendicular to a first direction in which the radiation is incident, and converting the radiation into visible light; a solar cell disposed on one side of the at least one optical disk, converting the visible light into an electrical signal; and a processing module for collecting and processing the electrical signal outputted from the solar cell.
    Type: Application
    Filed: March 10, 2023
    Publication date: September 14, 2023
    Applicants: NATIONAL CANCER CENTER, SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Dongho SHIN, Tae Hyun KIM, Tae-Ho KIM, Haksoo KIM, Dong-Seok SHIN, Se Byeong LEE, Youngkyung LIM, Jonghwi JEONG, Jaeman SON
  • Patent number: 11744461
    Abstract: The present disclosure relates to a retina imaging method in which a light from a light source into two lights is dispersed, at least one eyeground image of the eyeball at a first magnification is obtained by adjusting the paths of the two lights incident on the eyeball, and a plurality of DIC images are obtained at a second magnification higher than the first magnification with respect to the retina of the entirety of the obtained at least one eyeground image by adjusting the paths of the two lights incident on the eyeball.
    Type: Grant
    Filed: February 26, 2020
    Date of Patent: September 5, 2023
    Assignees: KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY, SEOUL NATIONAL UNIVERSITY HOSPITAL, INHA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION
    Inventors: Jae Hun Kim, Dae Yu Kim, Seok Hwan Kim, Youngho Cho, Byeongho Park, Hyo-suk Kim, Subeen Park, Kyoung Min Lee
  • Patent number: 11737917
    Abstract: An eye drop bottle storage unit for eye drop administration compliance includes a memory, a processor, and one or a plurality of eye drop bottle pods, where each eye drop bottle pod of the one or said plurality of eye drop bottle pods is configured to hold an eye drop bottle, and comprises one or a plurality of sensors. The memory is configured to store data of an eye drop administration regime of a subject. The processor is configured to receive signals from the one or said plurality of sensors of each eye drop bottle pod, and to determine from the received signals whether the subject administered eye drops into eyes of the subject from each eye drop bottle respectively held in each eye drop bottle pod of the one or said plurality of eye drop bottle pods in accordance with the eye drop administration regime data.
    Type: Grant
    Filed: August 17, 2018
    Date of Patent: August 29, 2023
    Assignees: NATIONAL UNIVERSITY HOSPITAL (SINGAPORE) PTE LTD, NATIONAL UNIVERSITY OF SINGAPORE
    Inventors: Victor Teck Chang Koh, Muhammad Azri Bin Razali, Teri Danielle You Ying Yeoh, Min Li Tey, Hui Chen Charmaine Chai, Yien Lai
  • Patent number: 11725248
    Abstract: The present invention provides methods of determining a survival predictor score of a subject having mantle cell lymphoma (MCL). The present invention also provides methods of predicting the survival outcome of a subject having MCL and provides methods of selecting a treatment for a subject having MCL.
    Type: Grant
    Filed: April 20, 2017
    Date of Patent: August 15, 2023
    Assignees: The United States of America, as represented by the Secretary, Department of Health and Human Services, British Columbia Cancer Agency Branch, Julius-Maximilians-University of Würzburg, Oregon Health & Science University, Hospital Clinic de Barcelona, Universitat de Barcelona, Oslo University Hospital HF, The Cleveland Clinic Foundation, Mayo Foundation for Medical Education and Research
    Inventors: Louis M. Staudt, David William Scott, George W. Wright, Andreas Rosenwald, Pau Abrisqueta, Rita Braziel, Elias Campo Guerri, Wing C. Chan, Joseph M. Connors, Jan Delabie, Diego Villa, Kai Fu, Randy D. Gascoyne, Timothy Greiner, Elaine S. Jaffe, Pedro Jares, Anja Mottok, German Ott, Lisa M. Rimsza, Graham Slack, Dennis Weisenburger, Erlend B. Smeland, James Robert Cook
  • Publication number: 20230248665
    Abstract: Provided is a composition comprising a dimethylchalcone derivative for prevention or treatment of metabolic diseases and, more specifically, to a compositioncomprising a derivative of 2?,4?-dihydroxy-6?-methoxy-3?,5?-dimethylchalcone as an active ingredient for the alleviation, prevention, or treatment of various metabolic diseases.
    Type: Application
    Filed: March 16, 2023
    Publication date: August 10, 2023
    Applicants: SEOUL NATIONAL UNIVERSITY R & DB FOUNDATION, SEOUL NATIONAL UNIVERSITY HOSPITAL, CHUNG-ANG UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION
    Inventors: Kyong Soo PARK, Sung Soo CHUNG, Ji Seon LEE, Kwang Yong PARK
  • Patent number: 11719778
    Abstract: Methods and systems generate synthetic late gadolinium enhancement (LGE) magnetic resonance images using a magnetic resonance fingerprinting (MRF) acquisition. From a single acquisition, MRF image data is obtained, including co-registered T1 and T2 tissue property maps. Different tissue regions of interest are identified, such as viable myocardium, scar, and blood and T1 and T2 values for each are determined. Based on these, different sets of pulse sequence parameters are determined, e.g., using different synthetic image contrast models receiving the MRF image data. Synthetic LGE images at different contrasts are generated as a result, including a synthetic bright-blood LGE image, a synthetic dark-blood/gray-blood LGE image, and a synthetic optimized imaged.
    Type: Grant
    Filed: January 31, 2022
    Date of Patent: August 8, 2023
    Assignees: REGENTS OF THE UNIVERSITY OF MICHIGAN, CASE WESTERN RESERVE UNIVERSITY, UNIVERSITY HOSPITALS CLEVELAND MEDICAL CENTER
    Inventors: Jesse Hamilton, Imran Rashid, Nicole Seiberlich, Sanjay Rajagopalan
  • Publication number: 20230242643
    Abstract: Chimeric antigen receptor (CAR) bridging protein are provided comprising a CAR-binding domain linked to an antigen-binding domain, which can be used to re-direct the targeting of CAR-T cells. The bridging protein may comprie an antigen-binding domain that targets any antigen of interest, such as, for example, a tumor antigen or viral antigen. Also provided are methods of using the bridging proteins in combination with CAR-T cells to treat a disease, such as, for example, a cancer or an infectious disease.
    Type: Application
    Filed: May 27, 2021
    Publication date: August 3, 2023
    Applicants: ANTION BIOSCIENCES SA, GENEVA UNIVERSITY HOSPITALS, UNIVERSITY OF GENEVA, UNIVERSITY OF ZURICH
    Inventors: Marco ALESSANDRINI, Karl-Heinz KRAUSE, Renier MYBURGH
  • Publication number: 20230235405
    Abstract: A marker composition, a kit, a gene panel, and a method which are for providing information for predicting the occurrence of, diagnosing, or treating age-related macular degeneration are disclosed. The marker composition, kit, gene panel, and method are novel tools that can provide information for predicting the occurrence of, diagnosing, or treating age-related macular degeneration, and has excellent sensitivity and can be easily analyzed without the use of a biopsy, and thus can be effectively used for the early diagnosis of age-related macular degeneration.
    Type: Application
    Filed: February 21, 2023
    Publication date: July 27, 2023
    Applicants: Genome Opinion Inc., Seoul National University Hospital
    Inventors: Choong Hyun Sun, Su Gyeong Kim, Ho Gune Im, Han Song, Baek Lok Oh, Su-Yeon Choi
  • Publication number: 20230235402
    Abstract: A composition suitable for diagnosing a musculoskeletal disease and a composition suitable for preventing or treating a musculoskeletal disease are disclosed. The composition contains zinc finger protein with KRAB and SCAN domains 8 (Zkscan8) protein, which can be effectively used as an excellent biomarker for obtaining accurate information about the occurrence and progression stages of a musculoskeletal disease, specifically a tendon disease or a ligament disease. The compositions containing Zkscan8 can be effectively used for preventing or treating a musculoskeletal disease through Zkscan8 overexpression.
    Type: Application
    Filed: July 2, 2021
    Publication date: July 27, 2023
    Applicants: SEOUL NATIONAL UNIVERSITY HOSPITAL, SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION, CHEONGJU UNIVERSITY INDUSTRY & ACADEMY COOPERATION FOUNDATION
    Inventors: Hyun Chul JO, Young-il HWANG, Jin-Hee KIM, Jin-Hong KIM, Jae-Hyung LEE, Hyun-Ju LIM, Ah-Young LEE, Seung Yeon LEE, Ji-Hye YEA, Yeasol KIM
  • Publication number: 20230226201
    Abstract: The present invention relates to a unit drug conjugate wherein a binding group capable of binding to another unit drug conjugate is additionally linked to a unit drug conjugate in which a targeting substance, which binds specifically to target cells, and a drug, are linked together. When the unit drug conjugates according to the present invention are sequentially administered in vivo, complexes form a cluster by in vivo crosslinking, and the cluster promotes endocytosis of the drug conjugate, thereby significantly enhancing cellular internalization of the drug included in the drug conjugate.
    Type: Application
    Filed: June 1, 2021
    Publication date: July 20, 2023
    Applicants: BIK THERAPEUTICS INC., SEOUL NATIONAL UNIVERSITY HOSPITAL
    Inventors: Sang Eun KIM, Byung Chul LEE, Hewon YOUN, Ji Young CHOI, Jae Ho JUNG, In Ho SONG
  • Publication number: 20230211009
    Abstract: A method for producing exosomes in a large-scale by using a cyclic tensile bioreactor to stimulate cells to release exosomes. In addition, the exosome having an anti-HLA-G protein specific for cancer is used as a delivery vehicle to deliver therapeutic agents for treating cancer.
    Type: Application
    Filed: December 2, 2022
    Publication date: July 6, 2023
    Applicants: CHINA MEDICAL UNIVERSITY, China Medical University Hospital, Shine-On Biomedical Co., Ltd.
    Inventors: Yi-Wen Chen, Der-Yang Cho, Hsin-Yuan Fang, Ming-You Shie, Chih-Ming Pan, Kai-Wen Kan, Cheng-Yu Chen, Min-Hua Yu, Shao-Chih Chiu
  • Patent number: 11690727
    Abstract: The present disclosure relates to an artificial ankle joint tibial component and, more particularly, to an artificial ankle joint tibial component of an implant that is implanted into a body, the implant including: a body part having a contact surface in contact with a resected surface of a distal end of a tibia of a joint and a joint surface facing a joint; and a fixing part formed to extend a predetermined length upwards from the contact surface, wherein the fixing part is configured as a single body formed to extent a predetermined length upwards from the center in the front area of the contact surface and includes a wing extending to one side, and wherein the wing includes at least one posterior wing that extends at a predetermined angle relative to an AP line, thereby preventing stress from being concentrated on one wing to avoid a fracture thereof and increasing the contact area between a bone and an implant to strengthen fixing force, prevent rotation, and disperse stress, so that bone resorption aroun
    Type: Grant
    Filed: August 28, 2018
    Date of Patent: July 4, 2023
    Assignees: CORENTEC CO., LTD., CHONNAM NATIONAL UNIVERSITY HOSPITAL, INDUSTRY FOUNDATION OF CHONNAM NATIONAL UNIVERSITY
    Inventors: Keun-Bae Lee, Tae-Jin Shin